Specialized Eye Diseases Hospital For Active Treatment-Varna EOOD
- Address
- lock Available on a paid plan
Specialized Eye Diseases Hospital For Active Treatment-Varna EOOD
The Specialized Eye Diseases Hospital For Active Treatment-Varna EOOD is a dedicated ophthalmic research center in Bulgaria with expertise in evaluating innovative treatments for sight-threatening retinal conditions. The center specializes in conducting clinical trials that assess both the efficacy and long-term safety of advanced therapeutic interventions for various forms of retinal disease.
- Neovascular age-related macular degeneration (nAMD) comparative efficacy studies
- Retinopathy of prematurity (ROP) treatment and long-term pediatric outcomes
- Anti-VEGF therapy evaluation and biosimilar comparisons
The hospital's research portfolio demonstrates significant experience in biosimilar development trials and pediatric ophthalmology follow-up studies. Their participation in extension studies reflects a commitment to understanding long-term treatment outcomes, particularly in vulnerable populations such as premature infants. The center's capabilities include precise visual acuity measurements using ETDRS protocols and comprehensive safety monitoring across diverse age groups, from neonatal patients to elderly populations with degenerative retinal conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 27 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Alvotech Swiss AG1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Bayer AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Specialized Eye Diseases Hospital For Active Treatment-Varna EOOD
lock Showing 1 of 13 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (22153) Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Aflibercept 8 mg in Macular Edema Secondary to Retinal Vein Occlusion | Bayer AG | Phase III | Not Recruiting | Sep 2023 | May 2025 |
IMP list
lock Showing 1 of 27 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aflibercept | 5 | Unknown | 2020-03-27 | 2026-03-31 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.